Most Popular Stories
- FDA approvals of 2011
- FDA maps out long-awaited rules for the biosimilars business
- Mouse study triggers demands for a possible Alzheimer's treatment
- High price of failure drives drug development costs into the stratosphere
- 13 Big Pharmas to collaborate on $785M fight against neglected diseases
- GSK, Takeda say nay to in-house diagnostics units
Webinars
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series) Increasingly, new technologies are making it possible to carefully identify sets of patien
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
Featured Jobs
-
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Manager Business Development
Clinical Resource Network - US West Coast
Events
- Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Just Released: New Trends in Preventive and Therapeutic Vaccine
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Launching a Medical Device, Healthcare or Life Science Product: Fail Fast, Marginal or Worth Pursuing?
- Tar Heel Biotech: The Policies, Trends, and Investments That Continue to Promote Growth in North Carolina's Biotechnology Sector
- The 3W Gaurrantee: What you Really Saved when you invest in Outsourced Talent
- Evidence for the existence of stable-water-clusters at room temperature and normal pressure
- Online Multilingual marketing strategy
- The FDA Review Process: a Technical Look
Rino Rappuoli
Novartis vaccine chief Rino Rappuoli
